Achieve Life Sciences, Inc.ACHVNASDAQ
Loading
Year-over-year earnings per share growth rate
5Y CAGR
-5.4%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q3 2025 | 24.32% |
| Q2 2025 | 0.00% |
| Q1 2025 | -2.78% |
| Q4 2024 | 0.00% |
| Q3 2024 | -44.00% |
| Q2 2024 | 3.85% |
| Q1 2024 | 0.00% |
| Q4 2023 | 23.53% |
| Q3 2023 | 20.93% |
| Q2 2023 | 14.00% |
| Q1 2023 | 38.27% |
| Q4 2022 | 42.14% |
| Q3 2022 | -23.89% |
| Q2 2022 | -34.52% |
| Q1 2022 | -10.53% |
| Q4 2021 | -7.04% |
| Q3 2021 | 53.59% |
| Q2 2021 | -17.69% |
| Q1 2021 | -68.83% |
| Q4 2020 | 32.46% |
| Q3 2020 | 32.14% |
| Q2 2020 | 21.86% |
| Q1 2020 | 63.62% |
| Q4 2019 | 34.84% |
| Q3 2019 | 10.02% |
| Q2 2019 | 42.63% |
| Q1 2019 | -60.90% |
| Q4 2018 | 23.58% |
| Q3 2018 | 60.81% |
| Q2 2018 | 25.01% |
| Q1 2018 | 22.34% |
| Q4 2017 | 65.05% |
| Q3 2017 | 18.21% |
| Q2 2017 | 8.37% |
| Q1 2017 | 44.18% |
| Q4 2016 | -58.30% |
| Q3 2016 | 46.58% |
| Q2 2016 | -85.19% |
| Q1 2016 | -115.11% |
| Q4 2015 | 63.76% |